Parkinson's Disease Therapeutics Market - Global Outlook and Forecast 2022-2028

January 2022 | 112 pages | ID: P3682BDBEC80EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Parkinson's Disease Therapeutics in Global, including the following market information:

Global Parkinson's Disease Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Parkinson's Disease Therapeutics market was valued at 2484.9 million in 2021 and is projected to reach US$ 3673.2 million by 2028, at a CAGR of 5.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Sinemet-CR Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Parkinson's Disease Therapeutics include Merck, Akorn, GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical, Abbvie, Kyowa Hakko Kirin Pharma and Astellas Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Parkinson's Disease Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Parkinson's Disease Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Parkinson's Disease Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Sinemet-CR
• Trastal
• Madopar
• COMT Inhibitor
• Other

Global Parkinson's Disease Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Parkinson's Disease Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Under 40 Years Old
• 40-65 Years Old
• Above 65 Years Old

Global Parkinson's Disease Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Parkinson's Disease Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Parkinson's Disease Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Parkinson's Disease Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• Akorn
• GSK
• Novartis
• Boehringer Ingelheim
• Teva Pharmaceutical
• Abbvie
• Kyowa Hakko Kirin Pharma
• Astellas Pharma
• Roche
• H.Lundbeck
• Bausch Health
• Apokyn
• Orion
• Stada Arzneimittel
• US WorldMeds
• Desitin Arzneimittel
• Endo Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Parkinson's Disease Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Parkinson's Disease Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PARKINSON'S DISEASE THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Parkinson's Disease Therapeutics Market Size: 2021 VS 2028
2.2 Global Parkinson's Disease Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Parkinson's Disease Therapeutics Players in Global Market
3.2 Top Global Parkinson's Disease Therapeutics Companies Ranked by Revenue
3.3 Global Parkinson's Disease Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Parkinson's Disease Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Parkinson's Disease Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Parkinson's Disease Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Parkinson's Disease Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Parkinson's Disease Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Parkinson's Disease Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Sinemet-CR
  4.1.3 Trastal
  4.1.4 Madopar
  4.1.5 COMT Inhibitor
  4.1.6 Other
4.2 By Type - Global Parkinson's Disease Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Parkinson's Disease Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Parkinson's Disease Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Parkinson's Disease Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Parkinson's Disease Therapeutics Market Size, 2021 & 2028
  5.1.2 Under 40 Years Old
  5.1.3 40-65 Years Old
  5.1.4 Above 65 Years Old
5.2 By Application - Global Parkinson's Disease Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Parkinson's Disease Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Parkinson's Disease Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Parkinson's Disease Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Parkinson's Disease Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Parkinson's Disease Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Parkinson's Disease Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Parkinson's Disease Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Parkinson's Disease Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Parkinson's Disease Therapeutics Revenue, 2017-2028
  6.3.2 US Parkinson's Disease Therapeutics Market Size, 2017-2028
  6.3.3 Canada Parkinson's Disease Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Parkinson's Disease Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Parkinson's Disease Therapeutics Revenue, 2017-2028
  6.4.2 Germany Parkinson's Disease Therapeutics Market Size, 2017-2028
  6.4.3 France Parkinson's Disease Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Parkinson's Disease Therapeutics Market Size, 2017-2028
  6.4.5 Italy Parkinson's Disease Therapeutics Market Size, 2017-2028
  6.4.6 Russia Parkinson's Disease Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Parkinson's Disease Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Parkinson's Disease Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Parkinson's Disease Therapeutics Revenue, 2017-2028
  6.5.2 China Parkinson's Disease Therapeutics Market Size, 2017-2028
  6.5.3 Japan Parkinson's Disease Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Parkinson's Disease Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Parkinson's Disease Therapeutics Market Size, 2017-2028
  6.5.6 India Parkinson's Disease Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Parkinson's Disease Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Parkinson's Disease Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Parkinson's Disease Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Parkinson's Disease Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Parkinson's Disease Therapeutics Market Size, 2017-2028
  6.7.3 Israel Parkinson's Disease Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Parkinson's Disease Therapeutics Market Size, 2017-2028
  6.7.5 UAE Parkinson's Disease Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck
  7.1.1 Merck Corporate Summary
  7.1.2 Merck Business Overview
  7.1.3 Merck Parkinson's Disease Therapeutics Major Product Offerings
  7.1.4 Merck Parkinson's Disease Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Merck Key News
7.2 Akorn
  7.2.1 Akorn Corporate Summary
  7.2.2 Akorn Business Overview
  7.2.3 Akorn Parkinson's Disease Therapeutics Major Product Offerings
  7.2.4 Akorn Parkinson's Disease Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Akorn Key News
7.3 GSK
  7.3.1 GSK Corporate Summary
  7.3.2 GSK Business Overview
  7.3.3 GSK Parkinson's Disease Therapeutics Major Product Offerings
  7.3.4 GSK Parkinson's Disease Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 GSK Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Parkinson's Disease Therapeutics Major Product Offerings
  7.4.4 Novartis Parkinson's Disease Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Novartis Key News
7.5 Boehringer Ingelheim
  7.5.1 Boehringer Ingelheim Corporate Summary
  7.5.2 Boehringer Ingelheim Business Overview
  7.5.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Major Product Offerings
  7.5.4 Boehringer Ingelheim Parkinson's Disease Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Boehringer Ingelheim Key News
7.6 Teva Pharmaceutical
  7.6.1 Teva Pharmaceutical Corporate Summary
  7.6.2 Teva Pharmaceutical Business Overview
  7.6.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Major Product Offerings
  7.6.4 Teva Pharmaceutical Parkinson's Disease Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Teva Pharmaceutical Key News
7.7 Abbvie
  7.7.1 Abbvie Corporate Summary
  7.7.2 Abbvie Business Overview
  7.7.3 Abbvie Parkinson's Disease Therapeutics Major Product Offerings
  7.7.4 Abbvie Parkinson's Disease Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Abbvie Key News
7.8 Kyowa Hakko Kirin Pharma
  7.8.1 Kyowa Hakko Kirin Pharma Corporate Summary
  7.8.2 Kyowa Hakko Kirin Pharma Business Overview
  7.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Major Product Offerings
  7.8.4 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Kyowa Hakko Kirin Pharma Key News
7.9 Astellas Pharma
  7.9.1 Astellas Pharma Corporate Summary
  7.9.2 Astellas Pharma Business Overview
  7.9.3 Astellas Pharma Parkinson's Disease Therapeutics Major Product Offerings
  7.9.4 Astellas Pharma Parkinson's Disease Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Astellas Pharma Key News
7.10 Roche
  7.10.1 Roche Corporate Summary
  7.10.2 Roche Business Overview
  7.10.3 Roche Parkinson's Disease Therapeutics Major Product Offerings
  7.10.4 Roche Parkinson's Disease Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Roche Key News
7.11 H.Lundbeck
  7.11.1 H.Lundbeck Corporate Summary
  7.11.2 H.Lundbeck Business Overview
  7.11.3 H.Lundbeck Parkinson's Disease Therapeutics Major Product Offerings
  7.11.4 H.Lundbeck Parkinson's Disease Therapeutics Revenue in Global Market (2017-2022)
  7.11.5 H.Lundbeck Key News
7.12 Bausch Health
  7.12.1 Bausch Health Corporate Summary
  7.12.2 Bausch Health Business Overview
  7.12.3 Bausch Health Parkinson's Disease Therapeutics Major Product Offerings
  7.12.4 Bausch Health Parkinson's Disease Therapeutics Revenue in Global Market (2017-2022)
  7.12.5 Bausch Health Key News
7.13 Apokyn
  7.13.1 Apokyn Corporate Summary
  7.13.2 Apokyn Business Overview
  7.13.3 Apokyn Parkinson's Disease Therapeutics Major Product Offerings
  7.13.4 Apokyn Parkinson's Disease Therapeutics Revenue in Global Market (2017-2022)
  7.13.5 Apokyn Key News
7.14 Orion
  7.14.1 Orion Corporate Summary
  7.14.2 Orion Business Overview
  7.14.3 Orion Parkinson's Disease Therapeutics Major Product Offerings
  7.14.4 Orion Parkinson's Disease Therapeutics Revenue in Global Market (2017-2022)
  7.14.5 Orion Key News
7.15 Stada Arzneimittel
  7.15.1 Stada Arzneimittel Corporate Summary
  7.15.2 Stada Arzneimittel Business Overview
  7.15.3 Stada Arzneimittel Parkinson's Disease Therapeutics Major Product Offerings
  7.15.4 Stada Arzneimittel Parkinson's Disease Therapeutics Revenue in Global Market (2017-2022)
  7.15.5 Stada Arzneimittel Key News
7.16 US WorldMeds
  7.16.1 US WorldMeds Corporate Summary
  7.16.2 US WorldMeds Business Overview
  7.16.3 US WorldMeds Parkinson's Disease Therapeutics Major Product Offerings
  7.16.4 US WorldMeds Parkinson's Disease Therapeutics Revenue in Global Market (2017-2022)
  7.16.5 US WorldMeds Key News
7.17 Desitin Arzneimittel
  7.17.1 Desitin Arzneimittel Corporate Summary
  7.17.2 Desitin Arzneimittel Business Overview
  7.17.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Major Product Offerings
  7.17.4 Desitin Arzneimittel Parkinson's Disease Therapeutics Revenue in Global Market (2017-2022)
  7.17.5 Desitin Arzneimittel Key News
7.18 Endo Pharmaceuticals
  7.18.1 Endo Pharmaceuticals Corporate Summary
  7.18.2 Endo Pharmaceuticals Business Overview
  7.18.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Major Product Offerings
  7.18.4 Endo Pharmaceuticals Parkinson's Disease Therapeutics Revenue in Global Market (2017-2022)
  7.18.5 Endo Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Parkinson's Disease Therapeutics Market Opportunities & Trends in Global Market
Table 2. Parkinson's Disease Therapeutics Market Drivers in Global Market
Table 3. Parkinson's Disease Therapeutics Market Restraints in Global Market
Table 4. Key Players of Parkinson's Disease Therapeutics in Global Market
Table 5. Top Parkinson's Disease Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Parkinson's Disease Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Parkinson's Disease Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Parkinson's Disease Therapeutics Product Type
Table 9. List of Global Tier 1 Parkinson's Disease Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Parkinson's Disease Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Parkinson's Disease Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Parkinson's Disease Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Parkinson's Disease Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Parkinson's Disease Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Parkinson's Disease Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Parkinson's Disease Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck Parkinson's Disease Therapeutics Product Offerings
Table 32. Merck Parkinson's Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Akorn Corporate Summary
Table 34. Akorn Parkinson's Disease Therapeutics Product Offerings
Table 35. Akorn Parkinson's Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. GSK Corporate Summary
Table 37. GSK Parkinson's Disease Therapeutics Product Offerings
Table 38. GSK Parkinson's Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Parkinson's Disease Therapeutics Product Offerings
Table 41. Novartis Parkinson's Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Boehringer Ingelheim Corporate Summary
Table 43. Boehringer Ingelheim Parkinson's Disease Therapeutics Product Offerings
Table 44. Boehringer Ingelheim Parkinson's Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Teva Pharmaceutical Corporate Summary
Table 46. Teva Pharmaceutical Parkinson's Disease Therapeutics Product Offerings
Table 47. Teva Pharmaceutical Parkinson's Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Abbvie Corporate Summary
Table 49. Abbvie Parkinson's Disease Therapeutics Product Offerings
Table 50. Abbvie Parkinson's Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Kyowa Hakko Kirin Pharma Corporate Summary
Table 52. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product Offerings
Table 53. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Astellas Pharma Corporate Summary
Table 55. Astellas Pharma Parkinson's Disease Therapeutics Product Offerings
Table 56. Astellas Pharma Parkinson's Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Roche Corporate Summary
Table 58. Roche Parkinson's Disease Therapeutics Product Offerings
Table 59. Roche Parkinson's Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. H.Lundbeck Corporate Summary
Table 61. H.Lundbeck Parkinson's Disease Therapeutics Product Offerings
Table 62. H.Lundbeck Parkinson's Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. Bausch Health Corporate Summary
Table 64. Bausch Health Parkinson's Disease Therapeutics Product Offerings
Table 65. Bausch Health Parkinson's Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 66. Apokyn Corporate Summary
Table 67. Apokyn Parkinson's Disease Therapeutics Product Offerings
Table 68. Apokyn Parkinson's Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 69. Orion Corporate Summary
Table 70. Orion Parkinson's Disease Therapeutics Product Offerings
Table 71. Orion Parkinson's Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 72. Stada Arzneimittel Corporate Summary
Table 73. Stada Arzneimittel Parkinson's Disease Therapeutics Product Offerings
Table 74. Stada Arzneimittel Parkinson's Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 75. US WorldMeds Corporate Summary
Table 76. US WorldMeds Parkinson's Disease Therapeutics Product Offerings
Table 77. US WorldMeds Parkinson's Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 78. Desitin Arzneimittel Corporate Summary
Table 79. Desitin Arzneimittel Parkinson's Disease Therapeutics Product Offerings
Table 80. Desitin Arzneimittel Parkinson's Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 81. Endo Pharmaceuticals Corporate Summary
Table 82. Endo Pharmaceuticals Parkinson's Disease Therapeutics Product Offerings
Table 83. Endo Pharmaceuticals Parkinson's Disease Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Parkinson's Disease Therapeutics Segment by Type in 2021
Figure 2. Parkinson's Disease Therapeutics Segment by Application in 2021
Figure 3. Global Parkinson's Disease Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Parkinson's Disease Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Parkinson's Disease Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Parkinson's Disease Therapeutics Revenue in 2021
Figure 8. By Type - Global Parkinson's Disease Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Parkinson's Disease Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Parkinson's Disease Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Parkinson's Disease Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Parkinson's Disease Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Parkinson's Disease Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Parkinson's Disease Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Parkinson's Disease Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Parkinson's Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Merck Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Akorn Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GSK Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Boehringer Ingelheim Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Teva Pharmaceutical Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Abbvie Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Astellas Pharma Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Roche Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. H.Lundbeck Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Bausch Health Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Apokyn Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Orion Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Stada Arzneimittel Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. US WorldMeds Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Desitin Arzneimittel Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Endo Pharmaceuticals Parkinson's Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)